Search Results 571-580 of 18307 for prostate cancer
This phase II trial studies how well hypofractionated radiation therapy works in treating participants with prostate cancer high-risk features following radical ...
The purpose of this study is to determine if prostate cancer patients treated with proton therapy as compared to IMRT experience improved QOL (validated EPIC ...
"It is truly just enlargement, and the cells in the prostate are not cancerous. Prostate enlargement is much more common than prostate cancer," he says. An ...
Each year about 90,000 men seek treatment for recurrent prostate cancer, and evaluating them for recurrence is a major challenge.
ICCaRE Consortium Pilot Project 1: Feasibility Of A Point Of Prostate Cancer Diagnosis Intervention For Newly Diagnosed Black Men · More about research at Mayo ...
... prostate cancer to find out which is better. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
... prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
When Bruce McVety's prostate cancer returned after a seven-year remission, his doctor suggested he go to Mayo Clinic to receive a test that wasn't available ...
Prostate cancer cells make excessive amounts of this protein, so an elevated or increasing PSA level is a possible sign of prostate cancer. That said, the ...
See a list of publications about prostate cancer by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. Research Profiles. Edit search ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.